分析得很对,最值得期待的是脂溢性皮炎。AD和PS竞争激烈,不说生物药,小分子就有$因塞特医疗(INCY)$ $Roivant Sciences(ROIV)$ 等。当然除了专科,$Arcutis(ARQT)$ 还在寻求合作者开拓primary care physicians的市场。我个人认为接近$10亿的销售是可能的...查看全文
真灼财经06-05 11:46
$信达生物(01801)$ 目前集团已取得10款产品获批上市,3个品种的新药上市申请(NDA)在国家药品监督管理局(NMPA)审评中,5个新药分子进入III期或关键性临床研究,另外还有18个新药品种已进入临床研究。今年第一季度,集团共取得总产品收入超过17亿元(人民币,下同),按年增加60%。期内,达伯舒...查看全文
因塞特医疗(INCY)05-01 04:05
$因塞特医疗(INCY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000879169-24-000077 Act: 34 Size: 7 MB 网页链接查看全文
因塞特医疗(INCY)05-10 06:35
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-057330 Size: 29 KB 网页链接查看全文
因塞特医疗(INCY)05-10 06:45
$因塞特医疗(INCY)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-059496 Act: 34 Size: 179 KB 网页链接查看全文
因塞特医疗(INCY)07-04 00:25
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000113 Size: 5 KB 网页链接查看全文
因塞特医疗(INCY)07-04 00:25
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000112 Size: 5 KB 网页链接查看全文
因塞特医疗(INCY)05-13 23:25
$因塞特医疗(INCY)$ SC TO-I Tender offer statement by Issuer Accession Number: 0001104659-24-060326 Act: 34 Size: 6 MB 网页链接查看全文
因塞特医疗(INCY)06-15 04:25
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073677 Size: 34 KB 网页链接查看全文
因塞特医疗(INCY)07-03 04:55
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080630 Size: 24 KB 网页链接查看全文
淡投2013-06-27 09:04
The share price of $因塞特医疗(INCY)$ recovered in Q1 due to a solid launch update for Jakafi for the treatment of myelofibrosis patients. With USD 136 mn in 2012 US sales and guidance of USD 210–225 mn and Novartis starting to ramp up the international launch, we see Jakafi...查看全文
淡投2012-04-26 23:16
$因塞特医疗(INCY)$ 7:01AM Incyte beats by $0.12, beats on revs (INCY) 19.40 : Reports Q1 (Mar) loss of $0.36 per share, $0.12 better than the Capital IQ Consensus Estimate of ($0.48); revenues rose 13.1% year/year to $36.2 mln vs the $25.3 mln consensus. Revenue for the quart...查看全文
方舟882012-01-13 17:09
【高盛集团发布报告预测今年最有可能被收购的几家公司】
$Dendreon(DNDN)$公司:2011年9月,该公司因前列腺癌疫苗Provenge销售不如预期而裁员25%。尽管Provenge是在美国批准用于治疗前列腺癌的首只免疫产品,但由于93000美元高昂的价格和支付问题,导致销量不佳。
$人类基因组科学(HGSI)$...查看全文
智通财经APP获悉,当地时间6月13日,美国FDA宣布批准礼来(LLY.US)和因塞特(INCY.US)联合开发的口服JAK抑制剂巴瑞替尼(英文商品名Olumiant)上市,用于治疗严重斑秃成人患者。值得一提的是,这是美国FDA批准用于治疗斑秃的首款系统性疗法... 网页链接
智通财经APP获悉,美国FDA于当地时间7月29日扩大了礼来(LLY.US)与因塞特医疗(INCY.US)的baricitinib药物(商用名Olumiant)的紧急适用授权(EUA)。根据修订后的EUA,治疗确诊新冠的住院患者时,baricitinib不需与吉利德科学(GILD.US)的Vekl... 网页链接
$因塞特医疗(INCY)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-005602 Act: 33 Size: 6 KB 网页链接
$因塞特医疗(INCY)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-24-082289 Size: 37 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000132 Size: 9 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000131 Size: 9 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000133 Size: 9 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000134 Size: 9 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000136 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000138 Size: 9 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000137 Size: 9 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000139 Size: 9 KB 网页链接